Biosimulation Market Size, Share & Trends Report

Biosimulation Market Size, Share & Trends Analysis Report By Product (Software, Services), By Application (Drug Development, Drug Discovery), By End Use, By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-1-68038-051-4
  • Number of Pages: 170
  • Format: Electronic (PDF)
  • Historical Range: 2017 - 2020
  • Industry: Healthcare

Table of Contents

Chapter 1 Biosimulation Market : Methodology and Scope
                   1.1 Market Segmentation and Scope
                       1.1.1 segment scope
                       1.1.2 regional scope
                       1.1.3 Estimates and forecast timeline
                   1.2 Research Methodology
                   1.3 Information procurement
                       1.3.1 Purchased database:
                       1.3.2 GVR’s internal database
                       1.3.3 Secondary sources
                       1.3.4 Primary research
                       1.3.5 Details of primary research
                   1.4 Information or Data Analysis
                       1.4.1 Data analysis models
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                   1.7 List of Secondary Sources
                   1.8 Objectives
                       1.8.1 Objective 1
                       1.8.2 Objective 2
                       1.8.3 Objective 3
                       1.8.4 Objective 4
Chapter 2 Biosimulation Market : Executive Summary
                   2.1 Biosimulation Market Summary
Chapter 3 Biosimulation Market: Variables, Trends & Scope
                   3.1 Biosimulation Market Segmentation and Scope
                   3.2 Biosimulation Market Dynamics
                       3.2.1 Market driver analysis
                       3.2.2 Impact analysis
                           3.2.2.1 Increasing adoption of Physiologically Based Pharmacokinetic Modeling in the regulatory approval process of drugs
                           3.2.2.2 Growing number of relapse cases due to increasing drug resistance
                           3.2.2.3 Rising Technological advancements
                           3.2.2.4 Increasing need to reduce drug discovery and development costs
                           3.2.2.5 accelerating formulation development and saving costly studies
                           3.2.2.6 Increasing investments in the life sciences industry
                           3.2.2.7 Increasing use of personalized medicine
                       3.2.3 Market restraint analysis
                       3.2.4 Impact analysis
                           3.2.4.1 Lack of standardization
                           3.2.4.2 Shortage of skilled professionals
                           3.2.4.3 Intellectual property protection and public policy issues
                   3.3 Penetration and Growth Prospect Mapping, 2021
                   3.4 Pricing Analysis
                   3.5 Biosimulation Market Analysis Tools: Porters
                       3.5.1 Bargaining power of Suppliers: Low
                       3.5.2 Bargaining power of Buyers: Moderate
                       3.5.3 Threat of Substitutes: Low
                       3.5.4 Threat of New Entrants: High
                       3.5.5 Competitive Rivalry: High
                   3.6 SWOT Analysis by Factors (Political & Legal, Economic, and Technological)
                       3.6.1 Political/Legal Landscape
                       3.6.2 Economic Landscape
                       3.6.3 Technology Landscape
Chapter 4 Biosimulation Market: Impact of COVID-19
                   4.1 Impact of Covid-19 on the Biosimulation Market
                       4.1.1 Current And Future Impact Analysis
                       4.1.2 Impact of covid-19 on market players
                       4.1.3 Disease Prevalence Analysis
Chapter 5 Biosimulation Market: Segment Analysis, By Product, 2017 - 2030 (USD Million)
                   5.1 Definition and Scope
                   5.2 Product Market Share Analysis, 2021 & 2030
                   5.3 Biosimulation Market, by Product, 2017 - 2030
                   5.4 Software
                       5.4.1 software market, 2017 - 2030 (USD Million)
                   5.5 Services
                       5.5.1 Services market, 2017 - 2030 (USD Million)
                       5.5.2 In-house Services
                           5.5.2.1 In-house Services market, 2017 - 2030 (USD Million)
                       5.5.3 Contract Services
                           5.5.3.1 Contract Services market, 2017 - 2030 (USD Million)
Chapter 6 Biosimulation Market: Segment Analysis, By Application, 2017 - 2030 (USD Million)
                   6.1 Definition and Scope
                   6.2 Application Market Share Analysis, 2021 & 2030
                   6.3 Biosimulation Market, by Application, 2017 - 2030
                   6.4 Drug Development
                       6.4.1 Drug development market, 2017 - 2030 (USD Million)
                   6.5 Drug Discovery
                       6.5.1 Drug Discovery market, 2017 - 2030 (USD Million)
                   6.6 Others
                       6.6.1 Others market, 2017 - 2030 (USD Million)
Chapter 7 Biosimulation Market: Segment Analysis, By Delivery Model, 2017 - 2030 (USD Million)
                   7.1 Definition and Scope
                   7.2 Application Market Share Analysis, 2021 & 2030
                   7.3 Biosimulation Market, by Delivery Model, 2017 - 2030
                   7.4 Subscription Models
                       7.4.1 Subscription Models market, 2017 - 2030 (USD Million)
                   7.5 Ownership Models
                       7.5.1 Ownership Models market, 2017 - 2030 (USD Million)
Chapter 8 Biosimulation Market: Segment Analysis, By End-use, 2017 - 2030 (USD Million)
                   8.1 Definition and Scope
                   8.2 End-use Market Share Analysis, 2021 & 2030
                   8.3 Global Biosimulation Market, by End-use, 2017 - 2030
                   8.4 Pharmaceutical & Biotechnology Companies
                       8.4.1 Pharmaceutical & biotechnology companies market, 2017 - 2030 (USD Million)
                   8.5 CROs
                       8.5.1 CROs market, 2017 - 2030 (USD million)
                   8.6 Regulatory Authorities
                       8.6.1 Regulatory authorities market, 2017 - 2030 (USD Million)
                   8.7 Academic Research Institutions
                       8.7.1 Academic research institutions market, 2017 - 2030 (USD million)
Chapter 9 Biosimulation Market: Regional Market Analysis 2017 - 2030 (USD Million)
                   9.1 Definition & Scope
                   9.2 Regional Market Share Analysis, 2022 & 2030
                   9.3 Regional Market Snapshot
                   9.4 Market Size, & Forecasts, and Trend Analysis, 2017 - 2030
                   9.5 North America
                       9.5.1 North America Biosimulation Market Share Analysis, by Country, 2022
                       9.5.2 U.S.
                           9.5.2.1 U.S. Biosimulation Market, 2017 - 2030 (USD Million)
                       9.5.3 Canada
                           9.5.3.1 Canada Biosimulation Market, 2017 - 2030 (USD Million)
                   9.6 Europe
                       9.6.1 Europe Biosimulation Market Share Analysis, by Country, 2022
                       9.6.2 UK
                           9.6.2.1 UK Biosimulation Market, 2017 - 2030 (USD Million)
                       9.6.3 Germany
                           9.6.3.1 Germany Biosimulation Market, 2017 - 2030 (USD Million)
                       9.6.4 France
                           9.6.4.1 France Biosimulation Market, 2017 - 2030 (USD Million)
                       9.6.5 Italy
                           9.6.5.1 Italy Biosimulation Market, 2017 - 2030 (USD Million)
                       9.6.6 Spain
                           9.6.6.1 Spain Biosimulation Market, 2017 - 2030 (USD Million)
                       9.6.7 Norway
                           9.6.7.1 Norway Biosimulation Market, 2017 - 2030 (USD Million)
                       9.6.8 Denmark
                           9.6.8.1 Denmark Biosimulation Market, 2017 - 2030 (USD Million)
                       9.6.9 Sweden
                           9.6.9.1 Sweden Biosimulation Market, 2017 - 2030 (USD Million)
                   9.7 Asia Pacific
                       9.7.1 Asia Pacific Biosimulation Market Share Analysis, by Country, 2022
                       9.7.2 Japan
                           9.7.2.1 Japan Biosimulation Market, 2017 - 2030 (USD Million)
                       9.7.3 China
                           9.7.3.1 China Biosimulation Market, 2017 - 2030 (USD million)
                       9.7.4 India
                           9.7.4.1 India Biosimulation Market, 2017 - 2030 (USD Million)
                       9.7.5 South Korea
                           9.7.5.1 South Korea Biosimulation Market, 2017 - 2030 (USD million)
                       9.7.6 Australia
                           9.7.6.1 Australia Biosimulation Market, 2017 - 2030 (USD Million)
                       9.7.7 Thailand
                           9.7.7.1 Thailand Biosimulation Market, 2017 - 2030 (USD Million)
                   9.8 Latin America
                       9.8.1 Latin America Biosimulation Market Share Analysis, by Country, 2022
                       9.8.2 Brazil
                           9.8.2.1 Brazil Biosimulation Market, 2017 - 2030 (USD Million)
                       9.8.3 Mexico
                           9.8.3.1 Mexico Biosimulation Market, 2017 - 2030 (USD Million)
                       9.8.4 Argentina
                           9.8.4.1 Argentina Biosimulation Market, 2017 - 2030 (USD Million)
                   9.9 MEA
                       9.9.1 MEA Biosimulation Market Share Analysis, by Country, 2022
                       9.9.2 South Africa
                           9.9.2.1 South Africa Biosimulation Market, 2017 - 2030 (USD Million)
                       9.9.3 Saudi Arabia
                           9.9.3.1 Saudi Arabia Biosimulation Market, 2017 - 2030 (USD Million)
                       9.9.4 UAE
                           9.9.4.1 UAE Biosimulation Market, 2017 - 2030 (USD Million)
                       9.9.5 Kuwait
                           9.9.5.1 Kuwait Biosimulation Market, 2017 - 2030 (USD Million)
Chapter 10 Biosimulation Market - Competitive Analysis
                   10.1 Strategy Framework
                   10.2 Market Participant Categorization
                   10.3 Public Companies
                       10.3.1 Company market position analysis
                       10.3.2 Comparative analysis by product category
                   10.4 Private Companies
                       10.4.1 List of Private companies
                       10.4.2 List of Emerging companies in the Asia Pacific Region
Chapter 11 Biosimulation Market - Company Profiles
                   11.1 Certara, USA
                       11.1.1 Company overview
                       11.1.2 Financial performance
                       11.1.3 Product benchmarking
                       11.1.4 Strategic initiatives
                   11.2 Simulations Plus
                       11.2.1 Company overview
                       11.2.2 Financial performance
                       11.2.3 Product benchmarking
                       11.2.4 Strategic initiatives
                   11.3 Dassault Systèmes
                       11.3.1 Company overview
                       11.3.2 Financial performance
                       11.3.3 Product benchmarking
                       11.3.4 Strategic initiatives
                   11.4 Schrödinger, Inc.
                       11.4.1 Company overview
                       11.4.2 Financial performance
                       11.4.3 Product benchmarking
                       11.4.4 Strategic initiatives
                   11.5 Advanced Chemistry Development
                       11.5.1 Company overview
                       11.5.2 Product benchmarking
                       11.5.3 Strategic initiatives
                   11.6 Chemical Computing Group ULC
                       11.6.1 Company overview
                       11.6.2 Financial performance
                       11.6.3 Product benchmarking
                       11.6.4 Strategic initiatives
                   11.7 Physiomics Plc
                       11.7.1 Company overview
                       11.7.2 Financial performance
                       11.7.3 Product benchmarking
                       11.7.4 Strategic initiatives
                   11.8 Rosa & Co. LLC
                       11.8.1 Company overview
                       11.8.2 Product benchmarking
                       11.8.3 Strategic initiatives
                   11.9 Biosimulation Consulting Inc.
                       11.9.1 Company overview
                       11.9.2 Financial performance
                       11.9.3 Service benchmarking
                   11.10 Genedata AG
                       11.10.1 Company overview
                       11.10.2 Financial performance
                       11.10.3 Product benchmarking
                       11.10.4 Strategic initiatives
                   11.11 Instem Group of Companies
                       11.11.1 Company overview
                       11.11.2 Financial performance
                       11.11.3 Product benchmarking
                       11.11.4 Strategic initiatives
                   11.12 PPD, Inc.
                       11.12.1 Company overview
                       11.12.2 Financial performance
                       11.12.3 Service benchmarking
                       11.12.4 Strategic initiatives
                   11.13 Yokogawa Insilico Biotechnology GmbH
                       11.13.1 Company overview
                       11.13.2 Product benchmarking
                       11.13.3 Strategic initiatives
                   11.14 Immunetrics
                       11.14.1 Company overview
                       11.14.2 Product benchmarking
Chapter 12 KOL Commentary


List of Tables

TABLE 1 List of secondary sources
TABLE 2 List of products for major companies
TABLE 3 List of private companies
TABLE 4 List of emerging companies
TABLE 5 North America biosimulation market, by country, 2017 - 2030 (USD Million)
TABLE 6 North America biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 7 North America biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 8 North America biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 9 North America biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 10 U.S. biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 11 U.S. biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 12 U.S. biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 13 U.S. biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 14 Canada biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 15 Canada biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 16 Canada biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 17 Canada biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 18 Europe biosimulation market, by country, 2017 - 2030 (USD Million)
TABLE 19 Europe biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 20 Europe biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 21 Europe biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 22 Europe biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 23 Germany biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 24 Germany biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 25 Germany biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 26 Germany biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 27 UK biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 28 UK biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 29 UK biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 30 UK biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 31 France biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 32 France biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 33 France biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 34 France biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 35 Italy biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 36 Italy biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 37 Italy biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 38 Italy biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 39 Spain biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 40 Spain biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 41 Spain biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 42 Spain biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 43 Norway biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 44 Norway biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 45 Norway biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 46 Norway biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 47 Denmark biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 48 Denmark biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 49 Denmark biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 50 Denmark biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 51 Sweden biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 52 Sweden biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 53 Sweden biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 54 Sweden biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 55 Asia Pacific biosimulation market, by country, 2017 - 2030 (USD Million)
TABLE 56 Asia Pacific biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 57 Asia Pacific biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 58 Asia Pacific biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 59 Asia Pacific biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 60 Japan biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 61 Japan biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 62 Japan biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 63 Japan biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 64 China biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 65 China biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 66 China biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 67 China biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 68 India biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 69 India biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 70 India biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 71 India biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 72 South Korea biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 73 South Korea biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 74 South Korea biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 75 South Korea biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 76 Australia biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 77 Australia biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 78 Australia biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 79 Australia biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 81 Thailand biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 82 Thailand biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 83 Thailand biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 84 Thailand biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 85 Latin America biosimulation market, by country, 2017 - 2030 (USD Million)
TABLE 86 Latin America biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 87 Latin America biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 88 Latin America biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 89 Latin America biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 90 Brazil biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 91 Brazil biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 92 Brazil biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 93 Brazil biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 94 Mexico biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 95 Mexico biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 96 Mexico biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 97 Mexico biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 98 Argentina biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 99 Argentina biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 100 Argentina biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 101 Argentina biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 102 MEA biosimulation market, by country, 2017 - 2030 (USD Million)
TABLE 103 MEA biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 104 MEA biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 105 MEA biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 106 MEA biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 107 South Africa biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 108 South Africa biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 109 South Africa biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 110 South Africa biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 111 Saudi Arabia biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 112 Saudi Arabia biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 113 Saudi Arabia biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 114 Saudi Arabia biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 115 UAE biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 116 UAE biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 117 UAE biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 118 UAE biosimulation market, by end-use, 2017 - 2030 (USD Million)
TABLE 119 Kuwait biosimulation market, by product, 2017 - 2030 (USD Million)
TABLE 120 Kuwait biosimulation services market, by type, 2017 - 2030 (USD Million)
TABLE 121 Kuwait biosimulation market, by application, 2017 - 2030 (USD Million)
TABLE 122 Kuwait biosimulation market, by end-use, 2017 - 2030 (USD Million)


List of Figures

FIG. 1 Biosimulation market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 Market formulation & validation
FIG. 8 Commodity Flow Analysis
FIG. 9 Biosimulation Market outlook (2022, USD Million)
FIG. 10 Biosimulation market segmentation and scope
FIG. 11 Biosimulation market dynamics analysis
FIG. 12 Biosimulation market driver and restraints impact analysis
FIG. 13 Biosimulation market driver analysis
FIG. 14 Biosimulation market drivers impact analysis
FIG. 15 R&D expenditures by various market players in 2022 (USD Million)
FIG. 16 Biosimulation market restraint impact
FIG. 17 Biosimulation market restraint impact analysis
FIG. 18 Penetration & growth prospect mapping
FIG. 19 COVID-19 new cases in major 35 countries around the world
FIG. 20 Biosimulation market: Product movement analysis
FIG. 21 Biosimulation market product outlook: Key takeaways
FIG. 22 Software market, 2017 - 2030 (USD Million)
FIG. 23 Services market, 2017 - 2030 (USD Million)
FIG. 24 In-house Services market, 2017 - 2030 (USD Million)
FIG. 25 Contract Services market, 2017 - 2030 (USD Million)
FIG. 26 Biosimulation market: Application movement analysis
FIG. 27 Biosimulation market application outlook: Key takeaways
FIG. 28 Drug development market, 2017 - 2030 (USD Million)
FIG. 29 Drug discovery market, 2017 - 2030 (USD Million)
FIG. 30 Others market, 2017 - 2030 (USD Million)
FIG. 31 Biosimulation market: End Use movement analysis
FIG. 32 Biosimulation market end use outlook: Key takeaways
FIG. 33 Pharmaceutical & biotechnology companies’ market, 2017 - 2030 (USD Million)
FIG. 34 CROs market, 2017 - 2030 (USD Million)
FIG. 35 Regulatory authorities market, 2017 - 2030 (USD Million)
FIG. 36 Academic research institutions market, 2017 - 2030 (USD Million)
FIG. 37 Regional outlook, 2022 & 2030
FIG. 38 Regional marketplace: Key takeaways
FIG. 39 North America Biosimulation market share, by country, 2022
FIG. 40 U.S. biosimulation market, 2017 - 2030 (USD Million)
FIG. 41 Canada biosimulation market, 2017 - 2030 (USD Million)
FIG. 42 Europe biosimulation market share analysis, by country, 2022
FIG. 43 UK Biosimulation market, 2017 - 2030 (USD Million)
FIG. 44 Germany biosimulation market, 2017 - 2030 (USD Million)
FIG. 45 France biosimulation market, 2017 - 2030 (USD Million)
FIG. 46 Italy Biosimulation market, 2017 - 2030 (USD Million)
FIG. 47 Spain biosimulation market, 2017 - 2030 (USD Million)
FIG. 48 Norway biosimulation market, 2017 - 2030 (USD Million)
FIG. 49 Sweden Biosimulation market, 2017 - 2030 (USD Million)
FIG. 50 Denmark biosimulation market, 2017 - 2030 (USD Million)
FIG. 51 Asia Pacific biosimulation market share analysis, by country, 2022
FIG. 52 Japan biosimulation market, 2017 - 2030 (USD Million)
FIG. 53 China biosimulation market, 2017 - 2030 (USD Million)
FIG. 54 India biosimulation market, 2017 - 2030 (USD Million)
FIG. 55 Australia biosimulation market, 2017 - 2030 (USD Million)
FIG. 56 South Korea biosimulation market, 2017 - 2030 (USD Million)
FIG. 57 Thailand biosimulation market, 2017 - 2030 (USD Million)
FIG. 58 Latin America Biosimulation market share analysis, by country, 2022
FIG. 59 Brazil biosimulation market, 2017 - 2030 (USD Million)
FIG. 60 Mexico Biosimulation market, 2017 - 2030 (USD Million)
FIG. 61 Argentina Biosimulation market, 2017 - 2030 (USD Million)
FIG. 64 MEA biosimulation market share analysis, by country, 2022
FIG. 65 South Africa biosimulation market, 2017 - 2030 (USD Million)
FIG. 66 Saudi Arabia biosimulation market, 2017 - 2030 (USD Million)
FIG. 67 UAE biosimulation market, 2017 - 2030 (USD Million)
FIG. 68 Kuwait biosimulation market, 2017 - 2030 (USD Million)
FIG. 69 Strategy framework
FIG. 70 Market participant categorization
FIG. 71 Biosimulation: Heat Map Analysis

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon